An emerging category of laboratory tests may help improve care and treatment outcomes for cancer patients, according to a recent survey by the nonprofit CancerCare, but insurers and employers do not ...

The National Council of Insurance Legislators moved closer to adopting a model law Friday after a robust debate on a biomarker testing coverage regulation. Members are expected to vote in July on the ...

That’s largely because many private and public health insurers won’t cover the $4,000-to-$8,000 expense. But an alliance of genetic testing companies, drugmakers, children’s hospitals, and doctors ...

Randomized Trial of a Volunteer-Led Symptom Assessment Intervention on Documentation, Patient-Reported Outcomes, and Health Care Use Among Veterans With Lung Cancer Among oncologists, 47.3%, 32.7%, ...

While I was reviewing a whitepaper titled Fuzzing Challenges: Metrics and Coverage, I thought the topic actually would deserve a wider analysis from the perspective of penetration testing. All the ...